Addison Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305K Sell
12,115
-5,108
-30% -$129K 0.14% 89
2026
Q1
$435K Buy
17,223
+555
+3% +$14.2K 0.1% 141
2025
Q4
$426K Hold
16,668
0.1% 142
2025
Q3
$427K Hold
16,668
0.1% 138
2025
Q2
$421K Buy
16,668
+7,005
+72% +$174K 0.11% 138
2025
Q1
$241K Buy
9,663
+1,310
+16% +$32.4K 0.07% 177
2024
Q4
$205K Sell
8,353
-415
-5% -$10.4K 0.06% 203
2024
Q3
$225K Buy
8,768
+415
+5% +$10.5K 0.06% 196
2024
Q2
$205K Buy
8,353
+3,088
+59% +$75.4K 0.07% 190
2024
Q1
$131K Buy
5,265
+2,630
+100% +$65.2K 0.04% 256
2023
Q4
$66.5K Buy
2,635
+2,215
+527% +$52.8K 0.03% 318
2023
Q3
$9.86K Buy
+420
New +$10.1K ﹤0.01% 486

Other funds holding IBDX

Addison Advisors's IBDX Position: Q2 2026 in Review

Addison Advisors reduced its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 30% in Q2 2026, selling an estimated $129K and leaving 12,115 shares worth $305K. The position accounts for 0.14% of the portfolio, ranked #89.

Addison Advisors first reported a position in IBDX in Q3 2023 and has held it in 12 quarters since. The position peaked at $435K in Q1 2026. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Addison Advisors held 12,115 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $305K as of Q2 2026.
  • Addison Advisors sold 5,108 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $129K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.14% of Addison Advisors's portfolio in Q2 2026, its #89 holding.
  • Addison Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2023 and has held it in 12 quarters since.
  • Addison Advisors's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $435K in Q1 2026.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.